Valneva SE (VALN)
NASDAQ·Healthcare·Biotechnology
$5.65
+1.44%
Mkt Cap $903.47M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+94.7%
Consensus $11.00 vs current $5.65
NASDAQ·Healthcare·Biotechnology
$5.65
+1.44%
Mkt Cap $903.47M
No recent rating data.
Price Target (4 analysts)
$11.00
Range $11.00 – $11.00
+94.7%
Consensus $11.00 vs current $5.65